Myelodysplastic patients with raised percentage of hypochromic red cells have evidence of functional iron deficiency

Ann Hematol. 2006 Jul;85(7):455-7. doi: 10.1007/s00277-006-0107-3. Epub 2006 Mar 28.

Abstract

Raised percentage hypochromic red cells (%HRC) were detected at diagnosis in 10 of 34 consecutive patients with low-risk myelodysplastic syndrome (MDS) [refractory anemia (RA) (4/26) and RA with ring sideroblasts (6/8)], all of whom had normal or increased serum ferritin and bone marrow iron stores. Elevated %HRC has persisted in all 10 cases and subsequently developed in another RA patient who later had a complete remission of MDS with normalisation of %HRC after a respiratory tract infection. A strong positive correlation was found between %HRC and erythrocyte zinc protoporphyrin levels in 11 MDS patients tested (p=0.01), suggesting that functional iron deficiency contributes to ineffective erythropoiesis in cases of MDS with raised %HRC. Five of seven patients with elevated %HRC had satisfactory haemoglobin responses to a trial of human recombinant erythropoietin without iron supplementation.

MeSH terms

  • Anemia, Hypochromic / epidemiology*
  • Anemia, Iron-Deficiency / blood
  • Anemia, Iron-Deficiency / epidemiology*
  • Blood Cell Count
  • C-Reactive Protein / analysis
  • Ferritins / blood
  • Humans
  • Iron / blood
  • L-Lactate Dehydrogenase / blood
  • Myelodysplastic Syndromes / blood*
  • Prevalence
  • Transferrin / metabolism

Substances

  • Transferrin
  • C-Reactive Protein
  • Ferritins
  • Iron
  • L-Lactate Dehydrogenase